Clin2
NCT07060443Possibly a fitRecruiting

Fluorescent dye study for right-sided colon cancer surgery

Right Hemicolectomy

Part of Cancer, Digestive system clinical trials.

This trial tests whether using a fluorescent dye during surgery can help doctors better see and remove lymph nodes in people with right-sided colon cancer. It aims to make surgery more precise and potentially improve outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
186 people
Ages
19 years to 85 years
Study type
Interventional

Who can take part

  • Must be between the ages of 19 and 85.
  • Have right-sided colon cancer that is locally advanced (stage cT3-4 N0 or cTany N1-2).
  • Cancer must be in the cecum, ascending colon, or nearby areas.
  • Must be in generally good health as defined by a standard scale (ASA I-III).
  • No allergy to iodine or iodine-based dyes.
  • No history of bleeding disorders or other active cancers.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06485609Recruiting
Dye-guided surgery for right colon cancer

This trial tests whether adding a special dye (indocyanine green) during surgery to remove right-sided colon cancer helps the surgeon see and remove more lymph nodes. The goal is to improve cancer removal without adding extra risks.

Guangzhou
NCT07638956Not yet recruiting
ICG dye during colon cancer surgery

This trial uses a special dye called ICG that is injected during surgery to help the surgeon see the blood flow to your colon and lymph nodes. It may help make the surgery more precise and improve outcomes for colon cancer.

NCT06583564Enrolling by invitation
ICG dye during surgery for stage III colorectal cancer

This study tests whether using a special dye during surgery helps people with stage III colorectal cancer stay cancer-free longer. The dye, called indocyanine green (ICG), makes tumors and lymph nodes glow under a special camera, helping surgeons remove them more precisely.

Changning, Shanghai Municipality
NCT06708819Not yet recruiting
Green dye imaging to improve bowel surgery outcomes

This trial tests a special green dye that helps surgeons see blood flow in the bowel during surgery. It may help reduce complications after removing part of the bowel for diseases like cancer or diverticulitis.

Dublin
NCT07303231Not yet recruiting· Phase 3
Using a fluorescent dye to guide lymph node removal during esophageal cancer surgery

This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.

Fuzhou, Fujian
NCT05369117Not yet recruiting
Fluorescent dye during laparoscopic surgery for upper stomach cancer

This trial tests whether using a special dye (called indocyanine green) during a minimally invasive laparoscopic surgery can help doctors see lymph nodes and cancer more clearly in patients with upper stomach cancer. The goal is to improve the precision of the surgery and possibly lead to better outcomes.

Hear when a new Right Hemicolectomy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.